BA
SNDX icon

BlackRock Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

BlackRock Advisors’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$7.37M Buy
1,027,672
+1,900
+0.2% +$20.8K 0.01% 993
2016
Q3 		$15.6M Sell
1,025,772
-1,130
-0.1% -$14.9K 0.02% 646
2016
Q2 		$10.1M Buy
1,026,902
+718,209
+233% +$9.85M 0.01% 823
2016
Q1 		$4.11M Buy
+308,693
New +$3.88M ﹤0.01% 1172

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock Advisors's SNDX Position: Q4 2016 in Review

BlackRock Advisors increased its Syndax Pharmaceuticals (SNDX) stake by 0.19% in Q4 2016, buying an estimated $20.8K and bringing the position to 1,027,672 shares worth $7.37M. The position accounts for 0.01% of the portfolio, ranked #993.

BlackRock Advisors first reported a position in SNDX in Q1 2016 and has held it in 4 quarters since. The position peaked at $15.6M in Q3 2016. 57 funds tracked by Wall St. Rank hold SNDX as of Q4 2016.

  • BlackRock Advisors held 1,027,672 shares of Syndax Pharmaceuticals worth $7.37M as of Q4 2016.
  • BlackRock Advisors bought 1,900 Syndax Pharmaceuticals shares in Q4 2016, an estimated $20.8K.
  • Syndax Pharmaceuticals made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #993 holding.
  • BlackRock Advisors first reported a position in Syndax Pharmaceuticals in Q1 2016 and has held it in 4 quarters since.
  • BlackRock Advisors's Syndax Pharmaceuticals position peaked at $15.6M in Q3 2016.
  • 57 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.